DEXTROSE 4.3 % AND SODIUM CHLORIDE 0.18 % INJECTION Israel - English - Ministry of Health

dextrose 4.3 % and sodium chloride 0.18 % injection

neopharm (israel) 1996 ltd - glucose anhydrous; sodium chloride - solution for injection - sodium chloride 0.18 g / 100 ml; glucose anhydrous 4.3 g / 100 ml - electrolytes - electrolytes - supply of water for administration of electrolytes or calories. vehicle for therapeutic regimen.

DEXTROSE 5 % AND SODIUM CHLORIDE 0.45 % INJECTION Israel - English - Ministry of Health

dextrose 5 % and sodium chloride 0.45 % injection

neopharm (israel) 1996 ltd - glucose anhydrous; sodium chloride - solution for injection - glucose anhydrous 5 g / 100 ml; sodium chloride 0.45 g / 100 ml - electrolytes - electrolytes - supply of water for administration of electrolytes or calories. vehicle for therapeutic regimen.

DEXTROSE 5 % AND SODIUM CHLORIDE 0.3 % AND POTASSIUM CHLORIDE 0.15% INJECTION Israel - English - Ministry of Health

dextrose 5 % and sodium chloride 0.3 % and potassium chloride 0.15% injection

neopharm (israel) 1996 ltd - glucose anhydrous; potassium chloride; sodium chloride - solution for injection - sodium chloride 0.3 g / 100 ml; potassium chloride 0.15 g / 100 ml; glucose anhydrous 5 g / 100 ml - electrolytes - electrolytes - supply of water for administration of electrolytes or calories. vehicle for therapeutic regimen.

DEXTROSE 5 % AND SODIUM CHLORIDE 0.33 % Israel - English - Ministry of Health

dextrose 5 % and sodium chloride 0.33 %

neopharm (israel) 1996 ltd - glucose anhydrous; sodium chloride - solution for injection - glucose anhydrous 5 g / 100 ml; sodium chloride 0.33 g / 100 ml - electrolytes - electrolytes - supply of water for administration of electrolytes or calories. vehicle for therapeutic regimen.

DEXTROSE 3.3 % AND SODIUM CHLORIDE 0.3 % INJECTION Israel - English - Ministry of Health

dextrose 3.3 % and sodium chloride 0.3 % injection

neopharm (israel) 1996 ltd - glucose anhydrous; sodium chloride - solution for injection - sodium chloride 0.3 g / 100 ml; glucose anhydrous 3.3 g / 100 ml - electrolytes - electrolytes - supply of water for administration of electrolytes or calories. vehicle for therapeutic regimen.

SODIUM CHLORIDE 0.45 % INJECTION Israel - English - Ministry of Health

sodium chloride 0.45 % injection

neopharm (israel) 1996 ltd - sodium chloride - solution for injection - sodium chloride 0.45 g / 100 ml - sodium chloride - sodium chloride - supply of water for administration of electrolytes. vehicle for therapeutic regimen.

AKNEMYCIN Israel - English - Ministry of Health

aknemycin

neopharm ltd - erythromycin - solution - external - erythromycin 2 % - erythromycin - erythromycin - all forms of acne, particularly inflammatory forms with papules and pustules.

VIDAZA Israel - English - Ministry of Health

vidaza

neopharm ltd - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azacitidine - for the treatment of patients with the following fab myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.

REVLIMID 5 MG Israel - English - Ministry of Health

revlimid 5 mg

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 5 mg - lenalidomide - lenalidomide - multiple myeloma (mm) revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

REVLIMID 5 MG Israel - English - Ministry of Health

revlimid 5 mg

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 5 mg - lenalidomide - lenalidomide - multiple myeloma (mm) revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.